Association of immune and proliferation gene signatures and stromal tumor-infiltrating lymphocytes with clinical outcomes in patients with stage I triple-negative breast cancer.

Tarantino P, Li T, Paré Brunet L, Sanfeliu E, Koca B, Guo R, Ollé-Monge M, Martínez-Sáez O, Cunningham O, Hughes ME, Patel A, King TA, Mittendorf EA, Lin NU, Brasó-Maristany F, Villacampa G, Villagrasa P, Tayob N, Prat A, Tolaney SM

Open source

DOI: 10.1016/j.ejca.2026.117020
Published: 2026 Sep 4
Container: European journal of cancer (Oxford, England : 1990)
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.ejca.2026.117020,
  title = {Association of immune and proliferation gene signatures and stromal tumor-infiltrating lymphocytes with clinical outcomes in patients with stage I triple-negative breast cancer.},
  author = {Tarantino P and Li T and Paré Brunet L and Sanfeliu E and Koca B and Guo R and Ollé-Monge M and Martínez-Sáez O and Cunningham O and Hughes ME and Patel A and King TA and Mittendorf EA and Lin NU and Brasó-Maristany F and Villacampa G and Villagrasa P and Tayob N and Prat A and Tolaney SM},
  year = {2026},
  journal = {European journal of cancer (Oxford, England : 1990)},
  doi = {10.1016/j.ejca.2026.117020},
  url = {https://doi.org/10.1016/j.ejca.2026.117020}
}

RIS

TY  - JOUR
TI  - Association of immune and proliferation gene signatures and stromal tumor-infiltrating lymphocytes with clinical outcomes in patients with stage I triple-negative breast cancer.
AU  - Tarantino P
AU  - Li T
AU  - Paré Brunet L
AU  - Sanfeliu E
AU  - Koca B
AU  - Guo R
AU  - Ollé-Monge M
AU  - Martínez-Sáez O
AU  - Cunningham O
AU  - Hughes ME
AU  - Patel A
AU  - King TA
AU  - Mittendorf EA
AU  - Lin NU
AU  - Brasó-Maristany F
AU  - Villacampa G
AU  - Villagrasa P
AU  - Tayob N
AU  - Prat A
AU  - Tolaney SM
PY  - 2026
JO  - European journal of cancer (Oxford, England : 1990)
DO  - 10.1016/j.ejca.2026.117020
UR  - https://doi.org/10.1016/j.ejca.2026.117020
ER  -

APA

P, T., T, L., L, P. B., E, S., B, K., R, G., M, O., O, M., O, C., ME, H., A, P., TA, K., EA, M., NU, L., F, B., G, V., P, V., N, T., A, P., & SM, T. (2026). Association of immune and proliferation gene signatures and stromal tumor-infiltrating lymphocytes with clinical outcomes in patients with stage I triple-negative breast cancer.. European journal of cancer (Oxford, England : 1990). https://doi.org/10.1016/j.ejca.2026.117020

Source records

pubmed · retrieved 2026-09-25T11:02:27.273Z